ETH Zurich researchers discover the potential of antidepressants in treating aggressive brain tumors like glioblastoma.

A new study has found that a cheap antidepressant available on the market could be used to treat the aggressive form of brain tumour, glioblastoma

Vortioxetine, an antidepressant, shows promise against glioblastoma in lab tests conducted by ETH Zurich, leading to forthcoming clinical trials. Glioblastoma is an incurable and fatal type of brain cancer.

Glioblastoma is a particularly aggressive brain tumor that at present is incurable. Cancer doctors can extend patients' life expectancy through operations, radiation, chemotherapy or surgical interventions.

A cheap antidepressant drug may be able to treat a particularly aggressive, currently incurable brain tumour, Swiss scientists found in early lab research. There are few treatments for glioblastoma, a common,